Radiation and cardiovascular disease.
作者信息
Palaskas Nicolas, Patel Ashley, Yusuf Syed Wamique
机构信息
University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Baylor College of Medicine, Houston, Texas, USA.
出版信息
Ann Transl Med. 2019 Dec;7(Suppl 8):S371. doi: 10.21037/atm.2019.08.107.
Abstract
摘要
相似文献
1
Radiation and cardiovascular disease.辐射与心血管疾病。
Ann Transl Med. 2019 Dec;7(Suppl 8):S371. doi: 10.21037/atm.2019.08.107.
2
Space radiation and cardiovascular disease risk.太空辐射与心血管疾病风险
World J Cardiol. 2015 Dec 26;7(12):882-8. doi: 10.4330/wjc.v7.i12.882.
3
Ionizing radiation and heart risks.电离辐射与心脏风险。
Semin Cell Dev Biol. 2016 Oct;58:14-25. doi: 10.1016/j.semcdb.2016.01.045. Epub 2016 Feb 2.
4
Radiation-associated cardiovascular disease: manifestations and management.辐射相关心血管疾病：表现与管理
Semin Radiat Oncol. 2003 Jul;13(3):346-56. doi: 10.1016/S1053-4296(03)00026-2.
5
Radiation-Induced Cardiovascular Disease.辐射诱发的心血管疾病
Curr Atheroscler Rep. 2017 May;19(5):22. doi: 10.1007/s11883-017-0658-x.
6
Heart in space: effect of the extraterrestrial environment on the cardiovascular system.太空之心：外星环境对心血管系统的影响。
Nat Rev Cardiol. 2018 Mar;15(3):167-180. doi: 10.1038/nrcardio.2017.157. Epub 2017 Oct 20.
7
The Role of NLRP3 Inflammasome in Radiation-Induced Cardiovascular Injury.NLRP3炎性小体在辐射诱导的心血管损伤中的作用
Front Cell Dev Biol. 2020 Mar 12;8:140. doi: 10.3389/fcell.2020.00140. eCollection 2020.
8
Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials.霍奇金淋巴瘤治疗后的心血管疾病：对九项欧洲癌症研究与治疗组织-淋巴瘤研究协会协作试验的分析
Lancet Haematol. 2015 Nov;2(11):e492-502. doi: 10.1016/S2352-3026(15)00153-2. Epub 2015 Oct 22.
9
Dose- and age-dependent cardiovascular mortality among inhabitants of the Chornobyl contaminated areas. 1988-2010 observation period.切尔诺贝利污染地区居民心血管疾病死亡率与剂量及年龄的关系。观察期为1988年至2010年。
Probl Radiac Med Radiobiol. 2014 Sep;19:59-66.
10
2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging-Best Practices for Safety and Effectiveness, Part 2: Radiological Equipment Operation, Dose-Sparing Methodologies, Patient and Medical Personnel Protection.2018年美国心脏病学会/心律学会/北美心血管影像学会/心血管造影和介入学会/心血管计算机断层扫描学会关于心血管成像中电离辐射最佳使用的专家共识文件——安全与有效性的最佳实践，第2部分：放射设备操作、剂量节省方法、患者及医务人员防护
Catheter Cardiovasc Interv. 2018 Aug 1;92(2):222-246. doi: 10.1002/ccd.27661. Epub 2018 Aug 29.
引用本文的文献
1
Cardiac toxicity and intervention strategies during thoracic cancer radiotherapy.胸段癌放疗期间的心脏毒性及干预策略
Front Oncol. 2025 Aug 4;15:1638035. doi: 10.3389/fonc.2025.1638035. eCollection 2025.
2
Bone marrow mesenchymal stem cell transplantation alleviates radiation-induced myocardial fibrosis through inhibition of the TGF-β1/Smad2/3 signaling pathway in rabbit model.骨髓间充质干细胞移植通过抑制兔模型中的TGF-β1/Smad2/3信号通路减轻辐射诱导的心肌纤维化。
Regen Ther. 2023 May 29;24:1-10. doi: 10.1016/j.reth.2023.04.003. eCollection 2023 Dec.
3
Association between radiotherapy and risk of death from cardiovascular diseases in lung and bronchus cancer.放疗与肺癌和支气管癌患者心血管疾病死亡风险之间的关联
Front Cardiovasc Med. 2023 Jan 12;9:1068957. doi: 10.3389/fcvm.2022.1068957. eCollection 2022.
4
Radiation-induced myocardial fibrosis: Mechanisms underlying its pathogenesis and therapeutic strategies.辐射诱导性心肌纤维化：发病机制及治疗策略的相关机制。
J Cell Mol Med. 2020 Jul;24(14):7717-7729. doi: 10.1111/jcmm.15479. Epub 2020 Jun 14.
本文引用的文献
1
Cancer treatment and survivorship statistics, 2019.2019 年癌症治疗与生存统计
CA Cancer J Clin. 2019 Sep;69(5):363-385. doi: 10.3322/caac.21565. Epub 2019 Jun 11.
2
MEDiastinal Irradiation and CArdio-Toxic Effects (MEDICATE): Exploring the Relationship between Cardiac Irradiation and High Sensitivity Troponins.纵隔放疗与心脏毒性效应（MEDICATE）：探究心脏放疗与高敏肌钙蛋白的关系。
Clin Oncol (R Coll Radiol). 2019 Jul;31(7):479-485. doi: 10.1016/j.clon.2019.04.003. Epub 2019 Apr 25.
3
Is mean heart dose a relevant surrogate parameter of left ventricle and coronary arteries exposure during breast cancer radiotherapy: a dosimetric evaluation based on individually-determined radiation dose (BACCARAT study).平均心脏剂量是否是乳腺癌放疗过程中左心室和冠状动脉暴露的相关替代参数：基于个体确定的辐射剂量的剂量学评估（BACCARAT 研究）。
Radiat Oncol. 2019 Feb 7;14(1):29. doi: 10.1186/s13014-019-1234-z.
4
Early Changes in Cardiovascular Biomarkers with Contemporary Thoracic Radiation Therapy for Breast Cancer, Lung Cancer, and Lymphoma.乳腺癌、肺癌和淋巴瘤采用当代胸部放射治疗后的心血管生物标志物的早期变化。
Int J Radiat Oncol Biol Phys. 2019 Mar 15;103(4):851-860. doi: 10.1016/j.ijrobp.2018.11.013. Epub 2018 Nov 14.
5
B-type natriuretic peptide plasma level in 5-year breast cancer survivors after radiotherapy.放疗后 5 年乳腺癌幸存者的 B 型利钠肽血浆水平。
Int J Radiat Biol. 2019 Feb;95(2):201-206. doi: 10.1080/09553002.2019.1542183. Epub 2018 Dec 3.
6
Deaths: Leading Causes for 2016.死亡：2016年的主要死因。
Natl Vital Stat Rep. 2018 Jul;67(6):1-77.
7
Radiation-Induced Cardiovascular Toxicity: Mechanisms, Prevention, and Treatment.辐射诱发的心血管毒性：机制、预防与治疗
Curr Treat Options Cardiovasc Med. 2018 Mar 20;20(4):31. doi: 10.1007/s11936-018-0627-x.
8
Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association.生物标志物在心衰的预防、评估和管理中的作用：美国心脏协会的科学声明。
Circulation. 2017 May 30;135(22):e1054-e1091. doi: 10.1161/CIR.0000000000000490. Epub 2017 Apr 26.
9
Cardiac Toxicity After Radiotherapy for Stage III Non-Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 Gy.Ⅲ期非小细胞肺癌放疗后的心脏毒性：70至90 Gy剂量递增试验的汇总分析
J Clin Oncol. 2017 May 1;35(13):1387-1394. doi: 10.1200/JCO.2016.70.0229. Epub 2017 Jan 23.
10
Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease.生长分化因子15作为心血管疾病的生物标志物
Clin Chem. 2017 Jan;63(1):140-151. doi: 10.1373/clinchem.2016.255174. Epub 2016 Oct 25.
Zotero 插件